1 completed, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow Pulmonary TB: new trials by email Literature Review of Pulmonary TB trials Research Report on Pulmonary TB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease Extra 600mg of Rifampicin, Placebo - Pulmonary TB | Phase 3 | Not yet recruiting | Hamilton Health Sciences Corporation | 1000 | 2026-02-01 | 2025-08-12 |
| Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis ATT (Ethambutol, Pyrazinamide, INH, Rifampicin) - HIV Infection, Pulmonary TB | Phase 3 | Completed | Tuberculosis Research Centre, India | 331 | 2009-09-14 | 2019-04-10 |
Tuberculosis, Pulmonary (2) · HIV Infections (1)
Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Lung Diseases (2) · Mycobacterium Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Tuberculosis (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Rifampin (2) · Ethambutol (1) · Isoniazid (1) · Pyrazinamide (1)
Hamilton Health Sciences Corporation (1) · Tuberculosis Research Centre, India (1)
India (1)
Christopher Cousins, MBChB PhD (1) · John Eikelboom, MBBS FRCPC (1) · Narendran Gopalan, DNB (Chest) (1) · Sean Wasserman, MBChB PhD (1) · Soumya Swaminathan, MD (1)